Neuberger Berman Group’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,185
Closed -$28.6K 2177
2025
Q4
$28.6K Buy
12,185
+1,985
+19% +$5.43K ﹤0.01% 2080
2025
Q3
$31.2K Buy
+10,200
New +$29.1K ﹤0.01% 2011
2020
Q4
Sell
-15,000
Closed -$187K 1683
2020
Q3
$187K Buy
+15,000
New +$166K ﹤0.01% 1570

Other funds holding CLOV

Neuberger Berman Group's CLOV Position: Q1 2026 in Review

Neuberger Berman Group sold out of Clover Health Investments (CLOV) in Q1 2026, closing a stake of 12,185 shares — an estimated $28.6K sold.

Neuberger Berman Group first reported a position in CLOV in Q3 2020 and held it in 3 quarters. The position peaked at $187K in Q3 2020. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Neuberger Berman Group reported no remaining Clover Health Investments position as of Q1 2026 after selling out during the quarter.
  • Neuberger Berman Group sold 12,185 Clover Health Investments shares in Q1 2026, an estimated $28.6K.
  • Neuberger Berman Group first reported a position in Clover Health Investments in Q3 2020 and held it in 3 quarters.
  • Neuberger Berman Group's Clover Health Investments position peaked at $187K in Q3 2020.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.